AXSM

Axsome Therapeutics, Inc.NASDAQHealthcare

$168.50-1.91%ClosedMarket Cap: $8.62B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-25	Guggenheim	—	Buy	—
2026-02-24	UBS	—	Buy	—
2026-02-24	RBC Capital	—	Outperform	—
2026-02-24	Wells Fargo	—	Overweight	—
2026-02-23	Needham	—	Buy	—
2026-02-03	Jefferies	—	Buy	—
2026-01-28	Leerink Partners	—	Outperform	—
2026-01-21	RBC Capital	—	Outperform	—
2026-01-20	HC Wainwright & Co.	—	Buy	—
2026-01-16	Piper Sandler	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$6.28	$1.54B	12
Sun Dec 31	$13.63	$2.12B	13
Mon Dec 31	$21.61	$2.79B	11
Tue Dec 31	$26.96	$3.30B	5